Phidippides cardiomyopathy: A review and case illustration

Clinical Cardiology

Volumn 35, Issue 2, 2012, Pages 69-73

  Trivax, Justin E ^a   McCullough, Peter A ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b St John Providence Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; CREATININE; CYSTATIN C; GALECTIN 3; MYOGLOBIN; NATRIURETIC PEPTIDE RECEPTOR B; TRANSFORMING GROWTH FACTOR BETA1; TROPONIN I;

ATHLETE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY ANOMALY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; ENDURANCE; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MARATHON RUNNER; NONHUMAN; PROTEIN EXPRESSION; QT INTERVAL; RESUSCITATION; REVIEW; ST SEGMENT; SUDDEN DEATH; TRAINING; UNITED STATES; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; RUNNING;

EID: 84857043553     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20994     Document Type: Review

References (25)

1. Thompson PD, Venero HC., A history of medical reports on the Boston Marathon: 112 years and still running. Med Sci Sports Exerc. 2009; 41: 1341-1348.
2. Douglas PS, O'Toole ML, Hiller WD, et al. Cardiac fatigue after prolonged exercise. Circulation. 1987; 76: 1206-1213. (Pubitemid 18007059)
3. Westrol MS, Kapitanyan R, Marques-Baptista A, et al. Causes of sudden cardiac arrest in young athletes. Postgrad Med. 2010; 122: 144-157.
4. Giada F, Biffi A, Cannom DS, et al. Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009. Eur J Cardiovasc Prev Rehabil. 2010; 17: 607-612.
5. Möhlenkamp S, Lehmann N, Breuckmann F, et al. Marathon Study Investigators; Heinz Nixdorf Recall Study Investigators. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008; 29: 1903-1910.
6. Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias: role of an electrophysiologic study in risk stratification. Eur Heart J. 2003; 24: 1473-1480. (Pubitemid 37010576)
7. Karjalainen J, Kujala UM, Kapiro J, et al. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ. 1998; 316: 1784-1785. (Pubitemid 28269153)
8. Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. J Appl Physiol. 2010; 108: 1148-1153.
9. Redelmeier DA, Greenwald JA., Competing risks of mortality with marathons: retrospective analysis. BMJ. 2007; 335: 1275-1277.
10. USA marathoning: 2007 overview. Accessed December 12, 2008.
11. La Gerche A, Connelly KA, Mooney DJ., Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart. 2008; 94: 860-866. (Pubitemid 351914694)
12. Krip B, Gledhill N, Jamnik V, et al. Effect of alterations in blood volume on cardiac function during maximal exercise. Med Sci Sports Exerc. 1997; 29: 1469-1476. (Pubitemid 27483992)
13. Neilan TG, Januzzi JL, Lee-Lewandrowski E, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation. 2006; 114: 2325-2333. (Pubitemid 44847449)
14. Breuckmann F, Möhlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009; 251: 50-57.
15. Knebel F, Schimke I, Schroeckh S, et al. Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers. J Am Soc Echocardiogr. 2009; 22: 803-809.
16. Fortescue EB, Shin AY, Greenes DS, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med. 2007; 49: 137-143.
17. McCullough PA, Chinnaiyan KM, Gallagher MJ, et al. Changes in renal markers and acute kidney injury after marathon running. Nephrology (Carlton). 2011; 16: 194-199.
18. Mousavi N, Czarneck A, Kumar K, et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol. 2009; 103: 1467-1472.
19. Benito B, Gay-Jordi G, Serrano-Mollar A, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation. 2011; 123: 13-22.
20. Kwak HB, Kim JH, Joshi K, et al. Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart. FASEB J. 2011; 25: 1106-1117.
21. McCullough PA., Integration of the clinical laboratory in cardiovascular medicine. Rev Cardiovasc Med. 2010; 11 (suppl 2):S1-S2.
22. Rowe WJ., A world record marathon runner with silent ischemia without coronary atherosclerosis. Chest. 1991; 99: 1306-1308.
23. Drezner JA., Contemporary approaches to the identification of athletes at risk for sudden cardiac death. Curr Opin Cardiol. 2008; 23: 494-501.
24. Prakken NH, Velthuis BK, Cramer MJ, et al. Advances in cardiac imaging: the role of magnetic resonance imaging and computed tomography in identifying athletes at risk. Br J Sports Med. 2009; 43: 677-684.
25. de Boer RA, Yu L, van Veldhuisen DJ., Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep. 2010; 7: 1-8.